Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma.

Published online

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Sivaraj, D; Green, MM; Kang, Y; Long, GD; Rizzieri, DA; Li, Z; Garrett, AH; McIntyre, JL; Chao, NJ; Gasparetto, C

Published Date

  • July 31, 2018

Published In

Volume / Issue

  • 8 / 8

Start / End Page

  • 71 -

PubMed ID

  • 30065277

Pubmed Central ID

  • 30065277

Electronic International Standard Serial Number (EISSN)

  • 2044-5385

Digital Object Identifier (DOI)

  • 10.1038/s41408-018-0104-5

Language

  • eng

Conference Location

  • United States